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Abstract
Purpose The objective of this study was to evaluate the
long-term outcome and prosthetic survival of primary total
knee arthroplasty in haemophilic patients. It was hypoth-
esized that the infection and revision rate are higher and the
outcome inferior when compared with patients without
haemophilia.
Methods Between 1985 and 2004, forty-three consecutive
primary total knee replacements were performed in thirty
haemophilic patients. These patients’ charts were reviewed
retrospectively. Twenty-five patients (34 knees) were
available for clinical and radiological follow-up. The out-
come was assessed using the Knee Society score, WOMAC
and Kaplan–Meier survivorship analysis.
Results An haematogenous infection occurred in two
patients. In three patients, component revision was needed:
two because of an infection and one because of a
mechanical failure. After a mean follow-up of 9.6 years
(2–20), 94% of the patients rated their result as either
excellent or good. At time of follow-up, the Knee Society
Score averaged 73.3 points (range, 29–100) and showed a
significant gain (p \ 0.001) compared to preoperative.
Flexion contracture could be reduced significantly
(p \ 0.001) from 18.1 preoperatively to 8.4 at follow-up,
whereas flexion remained unchanged. When infection or
any component replacement was set as endpoints, the
10 years prosthetic survival was 90 and 86%, respectively.
Conclusion Total knee arthroplasty in haemophilic
patients is a reliable treatment that results in pain relief and
functional improvement with a low risk of postoperative
infection. However, neither the postoperative infection rate
nor the functional result does reach the same level as in a
population not affected by haemophilia.
Level of evidence IV.
Keywords Knee  Total knee arthroplasty 
Haemophilia  Prosthetic survival
Introduction
Literature on total knee arthroplasty (TKA) in advanced
haemophilic knee arthropathy reports on varying results
and impact [7, 13, 15, 19, 21–23]. Besides of the generally
documented pain relief and functional improvement after
TKA, it is also known that the need for coagulation factor
concentrates is reduced postoperatively [3]. However, dif-
ferent reports have shown high rates of complications
including bleeding, deep infections and prosthetic failures
[15, 19, 21, 23]. Many series contain small numbers of
patients, or the follow-up period is short [3, 12, 13, 22].
There is only one study [7] demonstrating good results in a
larger collective with a long follow-up period.
The purpose of the present study was to evaluate the
subjective and objective outcome from a single centre
(with different orthopaedic surgeons) with a considerable
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number of patients and a long follow-up period after pri-
mary TKA in a haemophilic population and to evaluate the
rate and cause of failures. We hypothesized that the
infection and revision rate are higher and the long-term
outcome inferior than in the literature reporting on TKA in
patients without haemophilia.
Materials and methods
In a retrospective review, a consecutive, non-selective
series of haemophilic patients who underwent primary total
knee replacement at our institution was analysed. The
minimum follow-up time was 2 years. The study was
approved by the responsible investigational review board,
and all patients gave their written informed consent.
From 1985 to 2004, forty-three primary total knee
replacements were performed in thirty haemophilic patients.
The average age at time of surgery was 44 (range,
23–68 years). Twenty-six patients had a factor-VIII defi-
ciency (20 severe, five moderate and one mild) and four (one
severe and three moderate) had a factor-IX deficiency [25].
In addition, 4 patients (13%) were HIV positive and
their preoperative CD4 count averaged 406 cells/mm3
(range, 136–730 cells/mm3). Only one patient had a low
titter inhibitors against clotting factor.
According to the classification of Alberg et al. [2] and
Petersson et al. [17], the average grade of osteoarthritis
present was 4 (range, 3–5) and 8 (range, 4–10), respectively.
Surgery was performed bilaterally in 13 patients (43%).
Seven different implants were used: (21) Duracon (Stryker,
Kalamazoo, MI, USA), (10) porous-coated anatomic (PCA)
total knee replacement (Howmedica, Rutherford, NJ, USA),
(5) self aligning (SAL) knee prosthesis (Sulzer Medica,
Winterthur, Switzerland), (3) Innex (Sulzer Medica, Win-
terthur, Switzerland), (2) Wallaby II (Sulzer Medica, Win-
terthur, Switzerland), (1) Natural Knee (Zimmer, Warsaw,
IN, USA) and (1) Rotating hinge RT-Solution Endoplus
(Plus Orthopaedics, Rothkreut, Switzerland).
All patients were treated with their specific factor-VIII
or factor-IX product, they used for home-self-treatment, in
either prophylactic or majority on demand factor replace-
ment. Approximately two-third used plasmatic factor, and
the others used different recombinant factors. The treating
haematologists accompanied all surgeries from start of
anaesthesia until the end period of the procedure to ensure
sufficient factor replacement. For starting and during sur-
gery, factor level of 100% was aimed (reached by 50 IE
FVIII/per kg body weight, respectively, 80–100 IE FIX/kg
BW), usually by one dose before and the second dose after
opening of tourniquet calculated by the blood loss. The first
2 days either continuous infusion or injections every 4–6 h
were given aiming at factor levels between 70 and 100%.
From day 3, the dose was tapered to through levels between
50 and 70% up to day 6, then for another 3 days to through
levels between 40 and 60%. In our observation, day 9
seemed to be critical because of dropping off eschar from
the wounds; therefore, further dose reduction started only
at day 10. During the physiotherapy period, they had a full
prophylaxis to keep through level above 5–10%. All hae-
mophiliacs with severe or moderate did not receive medical
thrombosis prophylaxis.
Out of the thirty patients, four (five knees) had died due
to causes unrelated to surgery at a mean of 3.6 years
(range, 0.6–7.3) after the index procedure. One patient who
had emigrated could not be traced. The available clinical
and radiological data on these five patients were used for
the analysis. The remaining twenty-five patients (thirty-
seven knees) were available to complete follow-up exam-
inations. For those patients that had revision surgery, time
of the revision surgery was defined as follow-up endpoint.
Table 1 summarizes the population and provides details on
the evaluation.
Clinical assessment
Preoperatively as well as at the time of follow-up, the
clinical assessment included a structured interview and a
detailed, standardized physical examination. At the time
of follow-up, the Knee Society Clinical Rating System
(KSS) [9] and Western Ontario and McMaster OA Index
(WOMAC) [4] were recorded. The WOMAC consist of 24
items addressing the three dimensions: pain, stiffness and
physical function. Items were scored with a rating system
consisting of 5 grades (no = 0, mild = 2.5, moderate = 5,
severe = 7.5, extreme = 10 points). The dimension scores
were calculated as the mean of the items, with 10 repre-
senting worst pain, stiffness and physical function.
Table 1 Patient population
No
of
knees
No of
patients
Follow-up Evaluation
Total
(1985–2004)
43 30 8.6 years
(0.5–19.0)
Protheses
survivorship
preoperative knee
society score
chart review
Lost to
follow-up
(death)
6 5
Revised
before
follow-up
3 3 Post-knee society
score before
revision
Available for
follow-up
34 25 9.6 years
(2–20)
Post-knee society
score WOMAC
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Additionally, patients were asked to rate the result as
excellent, good, fair or poor. The follow-up interview and
clinical examination were completed by surgeons different
from the operating surgeons.
The patients’ charts were reviewed for preoperative co-
morbidities, to determine the preoperative KSS score, to
note remarkable intraoperative events and record postop-
erative complications (postoperative bleeding, infection,
revision surgery). Haematological charts were reviewed for
the patients HIV status, the CD 4 account and inhibitors
against clotting factor.
Radiological assessment
Preoperatively and at the time of follow-up, standard
radiographs (AP view, lateral view, patella sunrise view
and long-leg standing radiographs) were taken. However,
the preoperative conventional and long-leg standing
radiographs were available only in 39 and 21 patients,
respectively. The pre- and postoperative radiographs were
judged with regard to evaluation of the mechanical axis of
the leg and signs of loosening of the prosthesis.
Statistical analysis
Statistical analyses were performed by a statistical con-
sultant. The paired Wilcoxon signed-rank test was used to
compare the values at the time of diagnosis with those at
the time of follow-up. The Spearman rank correlation was
applied to correlate different variables. The Mann–Whitney
test was used for unpaired groups. Five and 10 years rates
of survival of the prostheses and their confidence intervals
were calculated with use of a Kaplan–Meier survival curve.
The endpoint for survivorship analysis was revision in
terms of either any components replacements and conver-
sion to an arthrodesis or an infection.
All statistical analyses were performed using SPSS 13.0
for MacIntosh OS X. The significance level was set at
p \ 0.05.
Results
Table 2 summarizes early and late postoperative compli-
cations. No clinical manifestation of thrombosis or pul-
monary embolism was observed.
Of the 43 total knee replacements, three were compli-
cated by an infection. Two were acute haematogenous
infections. Both were managed by surgical irrigation and
debridement and with an additional polyethylene inlay
exchange in one of them. A third infection was caused by a
direct trauma with knee perforation and rupture of the
patellar ligament. A conversion to an arthrodesis was
performed. This patient was not included for calculation of
infection-free prostetic survivalship.
Out of the 43 knees, three required component removal.
One patient had revision surgery because aseptic loosening
of the tibial component 9 years postoperatively. No spe-
cific reason for this early failure was found. The two other
patients, as mentioned earlier, had a replacement of the
polyethylene and a conversion to an arthrodesis,
respectively.
Table 3 summarizes the Knee Society Score, the WOMAC
and the subjective overall result at latest follow-up. Both,
Table 2 Postoperative complications
Number Postoperative complications
Details Management
Postoperative
haemarthrosis
11 1 joint aspiration
3 surgical evacuation
Arthrofibrosis 3 All had postoperative haemarthrosis Surgical arthrolysis at 3, 12 and 14 months
Infection 3 pt 1: acute haematogenous; HIV positive;
2 pneumococcus sepsis after 7 ? 9 years
pt 2: acute haematogenous; Staphylococcus aureus
pt 3: direct trauma with open wound ? rupture
of patellar ligament; secondary deep infection;
non-complaint drug abuser
Irrigation ? arthroscopic debridement after 7 years;
permanent antibiotic suppression after 9 years
Irrigation debridement polyethylene inlay exchange after 8 years
Arthrodesis after 2 years
Component
removal
3 pt 1: aseptic loosening tibial component
pt 2: acute haematogenous; Staphylococcus aureus
pt 3: secondary infection after direct trauma
Revision surgery with component removal after 9 years
Irrigation, debridement ? polyethylene inlay exchange after 8 years
Arthrodesis after 2 years
Additional
surgery
1 Persisting femoropatellar pain ? recurrent effusion Patella component implantation after 1 year
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the mean Knee Society clinical and functional Scores had
increased significantly (p \ 0.001) from pre- to postoper-
ative. Postoperative measurements of active motion dem-
onstrated that the mean average flexion contracture had
significantly decreased by 10 (p \ 0.001), but was not
normalized. No significant improvement was seen in
maximal knee flexion attained.
Standardized conventional radiographs and long-stand-
ing X-rays made at the time of follow-up were available for
all 37 knees. Radiographic results revealed signs of oste-
olysis or loosening of components in four patients.
Figure 1 illustrates implant survivorship with respect to
component removal and survivorship free of infection at
any point.
Discussion
The most important findings of the present study were that
surgery resulted in high patient’s satisfaction and in a
significant improvement of knee function. However, post-
operative knee flexion showed no improvement, and the
preoperative flexion contracture was significantly reduced
but not normalized. As it was hypothesized, the infection
and revision rate were higher and the clinical outcome
inferior than in the literature reporting on TKA in patients
without haemophilia.
Table 3 Pre- and postoperative
Knee Society Score, WOMAC
and subjective overall result
Preoperative Postoperative p-value
Mean Range SD Mean Range SD
Follow-up (years) 9.4 2–20
Age at follow-up (years) 53 36–80
Knee society clinical score
Pain (max., 50 points) 15 0–45 10 43 10–150 12 \0.001
Range of motion (max., 25 points) 14 0–26 6 16 4–25 6
Flexion 89 25–130 26 89 40–150 25
Flexion contracture 18 0–45 12 8 0–30 10 \0.001
Stability (max., 25 points) 24 15–25 3 24 15–25 3
Deductions (max., 50 points) 16 0–36 10 8 0–30 8 \0.001
Total score 36 15–90 16 73 29–100 18 \0.001
Knee society functional score
Walking (max., 50 points) 30 10–40 10 43 20–25 7 \0.001
Stairs (max., 50 points) 34 15–50 10 40 15–50 11 0.005
Deductions (max., 20 points) 2 0–10 4 0 0–10 2 0.003
Total score 62 15–90 19 83 40–100 15 \0.001
WOMAC
Pain 0.8 0–5 1.3
Stiffness 1.6 0–10 2.8
Function 1.9 0–6 1.9
Total 1.4 0–7 1.8
Subjective overall result 26 Excellent
8 Good
1 Fair
1 Poor
Fig. 1 Survivorship with respect to component removal for any
reason and free of infection at any point
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In this series, the infection rate was 5%. This is clearly
higher compared with the prevalence of infection of under
2% [10, 16, 18] in a non-haemophilic population and still
slightly increased, but consistent with the two most
recently reported series [7, 22] in haemophilics that have
shown a prevalence of 1.4 and 3%, respectively. However,
the infection rates in the literature in general for total knee
arthroplasty in haemophilic patients are ranging from 0 to
17% [13, 15, 23]. No concise and specific explanation can
be given for the relatively low infection rate in our series.
There is a continuing controversy in the literature
whether HIV infection increases the risk of infection.
Ragni et al. [19] reported a rate of 26% in HIV-positive
patients with haemophilia with CD4 counts \ 200 cells/
mm3. In accordance, Hicks et al. [8] demonstrated higher
rates of postoperative infection in patients’ sero-positive
for HIV. However, others [8, 15] could not find evidence
that a positive HIV status had any negative effects on the
infection rate. Therefore, it remains unknown if the rela-
tively small percentage of HIV-positive patients (9%) was
related to the low prevalence of infection in our collective.
Similarly, none of the two series [7, 22] with low infection
rate could provide an answer why infection had not been a
common problem in their collective. Most probably several
factors are responsible for successful reduction of the
infection rate, that is, adequate retroviral therapy at any
time, sufficient factor replacement perioperatively, appro-
priate antisepsis during self-administration of factor con-
centrates and prophylactic antibiotics before invasive
procedures with the potential risk for haematogenous
spread of bacteria. In contrast to many other treatment
centres, we never used medical thrombosis prophylaxis.
This might have contributed to very low wound haemor-
rhage in the postoperative period.
The knee society score in this population did not reach
the same level when compared with literature reporting on
results after TKA in non-haemophilic patients [1, 5, 20].
However, relevant pain relief after the procedure was seen.
In contrast, there was only a slight gain in ROM and only
the flexion contracture could be reduced successfully.
Nevertheless, patient’s satisfaction and the knee society
functional score were very high. The relatively fair range
of motion achieved postoperatively was despite a stan-
dardized and intensive physiotherapeutic rehabilitation
protocol known to play an important role [14] towards a
successful TKA in haemophilic patients.
The postoperative WOMAC confirmed that patients in
general had no or only mild pain, stiffness and considerably
good function in activities of daily living. This marked
discrepancy between subjective and objective results may
be explained by the fact that these patients had learned to
deal with increasing disability since their childhood and in
consequence less demanding with regard to sports
activities and/or are suffering from limitations due to
additional joint involvement.
With revision for any reason, we report of a five and
10 years prosthetic survival rate of 97 and 86%, respec-
tively. These results are comparable to those observed by
Goddard [7] (98% at 5 years; 87% at 10 years), Silva [23]
(83% at 10 years), Rodrigues-Marchand [22] (97% at
7.5 years) and Norian [15] (90% at 5 years), but less
favourable than in non-haemophilic patients with 90–97%
at 10–15 years follow-up [1, 5, 11, 20].
There are some limitations for this study. First, this is a
retrospective series with a limited number of patients what
is inherent to the small prevalence of the pathology.
However, we believe that the number is sufficient to allow
valuable conclusion. Second, this study is lacking of a
paired matched control group mainly because the difficul-
ties to identify patients of the same time period matching
for the typically young age and type of prosthesis. Never-
theless, the comparison of our data with literature on TKA
in non-haemophilic patients can highlight important dif-
ferences in the outcome.
With modern medical management, the life expectancy
of haemophilic patients is nearing that of the general
population, and the improvement in quality of life after
total knee arthroplasty may outweigh the moderately
higher risk of failure [13, 15]. However, with respect to this
permanent disorder, it remains most important to start
prophylactic treatment in early childhood [6, 24] to prevent
recurrent intra-articular bleeding to reduce the risk of
development of osteoarthritis. Therefore, continuous
patients support and guidance from a haematologist should
be established and particularly when total knee arthroplasty
becomes necessary surgery should be performed in a
comprehensive care centre allowing an interdisciplinary
approach. And even if most recent studies report survi-
vorships approaching those of non-haemophilics, patients
should be informed about the still inferior survival of a
total knee arthroplasty in haemophilics.
Conclusion
Total knee arthroplasty in haemophilic patients is a reliable
treatment that provides relevant benefits in terms of pain
reduction and functional improvement. With a specialized
multidisciplinary management, rates of postoperative
complications and implant failures may be reduced. Never-
theless, when compared with a non-haemophiliac popula-
tion, less favourable infection and survival rates as well as
functional results must be expected.
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